LONG R3 IGF-I RECOMBINANT ANALOG
143045-27-6
|
Insulin-Like Growth Factor I (30-41)
82177-09-1
|
IGF-I 24-41
135861-49-3
|
rec IGF-I(human)
67763-96-6
|
Oxiranecarboxamide, 3-methyl-2-(1-methylethyl)-, (2R,3R)- (9CI)
200356-10-1
|
rec IGF-II (1-67) (human)
96081-16-2
|
Ethyl-Tianeptine-I
1809277-99-3
|
C6H5OB(O-i-C4H9)2
109312-25-6
|
o-tolylthiolatosilver(I)
70247-11-9
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
N-(5-(1-(thiophen-2-yl)cyclopentanecarbonyl)-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)furan-2-carboxamide
1351631-63-4
|
6-Methylthieno[2,3-C]pyridin-7(6H)-one
1849330-56-8
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
(1alpha,4alpha)-2-Azabicyclo[2.2.0]hex-5-en-3-one
332011-92-4
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
Methyl 7-bromo-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxylate
1119833-02-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
